NEWARK, Del., July 14, 2021 /PRNewswire/ — Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) confirms that it has received $153M in new funding from the National Institute of Standards and Technology (NIST) as announced by U.S. Commerce Secretary Gina Raimondo at NIIMBL’s National Meeting in Washington, DC. The two awards include $70M to continue federal funding for NIIMBL for an additional five years and an additional $83M for coronavirus response projects under the American Rescue Plan (ARP).
{iframe}https://www.galvnews.com/news_ap/business/article_69385c95-d9e7-5af8-a056-c23aa5a823e1.html{/iframe}